Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Pivotal Trial to Assess the Efficacy of AKL-T01, a Novel Digital Intervention Designed to Improve Attention, in Adolescents, Aged 13-17 Years Old, Diagnosed With Attention Deficit Hyperactive Disorder (ADHD)

NCT04897074 is registered in ClinicalTrials.gov with Akili Interactive Labs, Inc. as lead sponsor.

NCT NCT04897074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04897074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Pivotal Trial to Assess the Efficacy of AKL-T01, a Novel Digital Intervention Designed to Improve Attention, in Adolescents, Aged 13-17 Years Old, Diagnosed With Attention Deficit Hyperactive Disorder (ADHD)
Lead sponsor
Akili Interactive Labs, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2021
Completion date
September 1, 2022
Enrollment
165 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder